Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome
Clinical trial NCT07233330 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07233330
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2029-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.